Clinical trial
Anti-Oxidant Treatment of Alzheimer's Disease
NCT00117403 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00117403 |
|---|---|
| Title | Anti-Oxidant Treatment of Alzheimer's Disease |
| Official title | Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Vitamin E, Vitamin C, and Alpha-lipoic Acid, Coenzyme Q, Placebo capsules, Placebo wafers |
| Enrollment | 75 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 6, 2005 |
| Last update posted | Apr 3, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: